LAMP1 and nonpapillary renal cell carcinoma: Subgroup analysis of ccRCC patients revealed that those with low LAMP1 expression had poorer overall survival in Stage T3&4, T3, M1, G3&4, Stage III&IV, and Stage IV (Figures 3D–I, P< 0.05).